Published in Blood Weekly, December 18th, 1995
Malech has treated the first patients in a novel Phase I clinical trial of progenitor cell gene therapy for the rare hereditary disorder, chronic granulomatous disease (CGD). In the five patient trial, three patients are far enough into treatment for analysis and preliminary evaluation. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.